{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T20:10:30Z","timestamp":1788207030625,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annalsofoncology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.annonc.2025.03.002","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T03:32:59Z","timestamp":1741577579000},"page":"693-703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Oncologic outcomes of retroperitoneal lymph node dissection following first-line chemotherapy for metastatic non-seminomatous germ-cell tumors"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0757-0885","authenticated-orcid":false,"given":"R.S.","family":"Matulewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6903-2540","authenticated-orcid":false,"given":"F.","family":"Baky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Liso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3163-3304","authenticated-orcid":false,"given":"S.","family":"Porwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Assel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.S.","family":"Carver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.F.","family":"Bajorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Motzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.J.","family":"Bosl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.E.","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9775-0478","authenticated-orcid":false,"given":"S.K.","family":"Tickoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Al-Ahmadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Vickers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7235-6319","authenticated-orcid":false,"given":"S.A.","family":"Funt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2424-4635","authenticated-orcid":false,"given":"D.R.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sheinfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.annonc.2025.03.002_bib1","first-page":"2630","article-title":"Testicular cancer: an oncological success story","volume":"3","author":"Einhorn","year":"1997","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.annonc.2025.03.002_bib2","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1200\/JCO.1988.6.8.1239","article-title":"Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up","volume":"6","author":"Roth","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annonc.2025.03.002_bib3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1200\/JCO.2009.23.0714","article-title":"Long-term follow-up of cisplatin combination chemotherapy in patients with disseminated nonseminomatous germ cell tumors: is a postchemotherapy retroperitoneal lymph node dissection needed after complete remission?","volume":"28","author":"Ehrlich","year":"2009","journal-title":"J Clin Oncol"},{"issue":"28","key":"10.1016\/j.annonc.2025.03.002_bib4","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1200\/JCO.2014.56.0896","article-title":"Testicular cancer: a reflection on 50 years of discovery","volume":"32","author":"Hanna","year":"2014","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.annonc.2025.03.002_bib5","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1200\/JCO.1993.11.4.598","article-title":"Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study","volume":"11","author":"Bajorin","year":"1993","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.annonc.2025.03.002_bib6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/onco.13719","article-title":"Four cycles of etoposide plus cisplatin for patients with good-risk advanced germ cell tumors","volume":"26","author":"Funt","year":"2021","journal-title":"Oncologist"},{"issue":"26","key":"10.1016\/j.annonc.2025.03.002_bib7","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1200\/JCO.18.01608","article-title":"Impact of teratoma on the cumulative incidence of disease-related death in patients with advanced germ cell tumors","volume":"37","author":"Funt","year":"2019","journal-title":"J Clin Oncol"},{"issue":"34","key":"10.1016\/j.annonc.2025.03.002_bib8","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1200\/JCO.2007.15.7453","article-title":"Clinical outcome and predictors of survival in late relapse of germ cell tumor","volume":"26","author":"Sharp","year":"2008","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.annonc.2025.03.002_bib9","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1200\/JCO.1995.13.5.1177","article-title":"Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups","volume":"13","author":"Steyerberg","year":"1995","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.annonc.2025.03.002_bib10","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/JU.0000000000001960","article-title":"Percentage of teratoma in orchiectomy and risk of retroperitoneal teratoma at the time of postchemotherapy retroperitoneal lymph node dissection in germ cell tumors","volume":"206","author":"Calaway","year":"2021","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.annonc.2025.03.002_bib11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0022-5347(06)00508-8","article-title":"Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection","volume":"176","author":"Carver","year":"2006","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.annonc.2025.03.002_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.eururo.2023.04.010","article-title":"European Association of Urology guidelines on testicular cancer: 2023 update","volume":"84","author":"Patrikidou","year":"2023","journal-title":"Eur Urol"},{"issue":"12","key":"10.1016\/j.annonc.2025.03.002_bib13","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.6004\/jnccn.2019.0058","article-title":"Testicular cancer, version 2.2020, NCCN clinical practice guidelines in oncology","volume":"17","author":"Gilligan","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"issue":"12","key":"10.1016\/j.annonc.2025.03.002_bib14","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1002\/cncr.23104","article-title":"Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection","volume":"110","author":"Spiess","year":"2007","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.annonc.2025.03.002_bib15","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1097\/01.ju.0000119121.36427.09","article-title":"Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group","volume":"171","author":"Albers","year":"2004","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.annonc.2025.03.002_bib16","first-page":"65","article-title":"Integration of surgery and systemic therapy: results and principles of integration","volume":"16","author":"Donohue","year":"1998","journal-title":"Semin Urol Oncol"},{"issue":"5","key":"10.1016\/j.annonc.2025.03.002_bib17","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0022-5347(17)39044-4","article-title":"Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer","volume":"142","author":"Foss\u00e5","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.annonc.2025.03.002_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114042","article-title":"Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: results from the IGCCCG Update Consortium","volume":"202","author":"B\u00fchrer","year":"2024","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.annonc.2025.03.002_bib19","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1159\/000515715","article-title":"Teratomatous elements in orchiectomy specimens are associated with a reduced relapse-free survival in metastasized testicular germ cell tumors","volume":"106","author":"Paffenholz","year":"2022","journal-title":"Urol Int"},{"key":"10.1016\/j.annonc.2025.03.002_bib20","series-title":"R: a language and environment for statistical computing","year":"2021"},{"issue":"43","key":"10.1016\/j.annonc.2025.03.002_bib21","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Softw"},{"issue":"1","key":"10.1016\/j.annonc.2025.03.002_bib22","first-page":"570","article-title":"Reproducible summary tables with the gtsummary package","volume":"13","author":"Sjoberg","year":"2021","journal-title":"R Journal"},{"key":"10.1016\/j.annonc.2025.03.002_bib23","author":"Therneau"},{"key":"10.1016\/j.annonc.2025.03.002_bib24","author":"Wood"},{"issue":"3","key":"10.1016\/j.annonc.2025.03.002_bib25","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/JU.0000000000002751","article-title":"Surveillance after complete response to first-line chemotherapy in patients with metastatic nonseminomatous germ cell tumor","volume":"208","author":"King","year":"2022","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.annonc.2025.03.002_bib26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.euo.2021.02.002","article-title":"Unilateral or bilateral retroperitoneal lymph node dissection in nonseminoma patients with postchemotherapy residual tumour? Results from RETROP, a population-based mapping study by the Swedish Norwegian Testicular Cancer Group","volume":"5","author":"Gerdtsson","year":"2022","journal-title":"Eur Urol Oncol"},{"issue":"4","key":"10.1016\/j.annonc.2025.03.002_bib27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.2009.23.0755","article-title":"Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery","volume":"28","author":"Kollmannsberger","year":"2010","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.annonc.2025.03.002_bib28","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.juro.2016.09.113","article-title":"Clinical outcome of patients with fibrosis\/necrosis at post-chemotherapy retroperitoneal lymph node dissection for advanced germ cell tumors","volume":"197","author":"Mano","year":"2017","journal-title":"J Urol"},{"issue":"25","key":"10.1016\/j.annonc.2025.03.002_bib29","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1200\/JCO.2005.11.684","article-title":"Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection","volume":"23","author":"Beck","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.annonc.2025.03.002_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2024.102217","article-title":"Long-term clinical outcomes of patients with negative pathology (pN0) at primary retroperitoneal lymph node dissection","volume":"22","author":"Baky","year":"2024","journal-title":"Clin Genitourin Cancer"},{"issue":"2","key":"10.1016\/j.annonc.2025.03.002_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.euo.2020.08.007","article-title":"Long-term surveillance of patients with complete response following chemotherapy for metastatic nonseminomatous germ cell tumor","volume":"4","author":"Nason","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"10.1016\/j.annonc.2025.03.002_bib32","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.urology.2008.08.501","article-title":"Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer","volume":"73","author":"Pettus","year":"2009","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.annonc.2025.03.002_bib33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.euo.2019.08.002","article-title":"Surgical complications in postchemotherapy retroperitoneal lymph node dissection for nonseminoma germ cell tumour: a population-based study from the Swedish Norwegian Testicular Cancer Group","volume":"3","author":"Gerdtsson","year":"2020","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"10.1016\/j.annonc.2025.03.002_bib34","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/annonc\/mdw605","article-title":"Surgical management of complex residual masses following systemic chemotherapy for metastatic testicular germ cell tumours","volume":"28","author":"Heidenreich","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.annonc.2025.03.002_bib35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.urology.2016.01.010","article-title":"Characterizing the morbidity of postchemotherapy retroperitoneal lymph node dissection for testis cancer in a national cohort of privately insured patients","volume":"91","author":"Macleod","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.annonc.2025.03.002_bib36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejca.2022.12.032","volume":"182","author":"Antonelli","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.annonc.2025.03.002_bib37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.urology.2018.01.014","article-title":"Clinical outcome of retroperitoneal lymph node dissection after chemotherapy in patients with pure embryonal carcinoma in the orchiectomy specimen","volume":"114","author":"Dowling","year":"2018","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.annonc.2025.03.002_bib38","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.eururo.2021.06.006","article-title":"Circulating microRNAs, the next-generation serum biomarkers in testicular germ cell tumours: a systematic review","volume":"80","author":"Le\u00e3o","year":"2021","journal-title":"Eur Urol"},{"issue":"20","key":"10.1016\/j.annonc.2025.03.002_bib39","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.3390\/cancers13205228","article-title":"Combining hypermethylated RASSF1A detection using ddPCR with miR-371a-3p testing: an improved panel of liquid biopsy biomarkers for testicular germ cell tumor patients","volume":"13","author":"Lobo","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.annonc.2025.03.002_bib40","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/jnci\/91.10.839","volume":"91","author":"Collette","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"8851","key":"10.1016\/j.annonc.2025.03.002_bib41","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0140-6736(93)91082-W","article-title":"Management of malignant teratoma: does referral to a specialist unit matter?","volume":"341","author":"Harding","year":"1993","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.annonc.2025.03.002_bib42","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/jnci\/91.10.816","article-title":"Does size matter? Association between number of patients treated and patient outcome in metastatic testicular cancer","volume":"91","author":"Feuer","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.annonc.2025.03.002_bib43","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00345-009-0412-2","article-title":"Management of post-chemotherapy extra-retroperitoneal residual masses","volume":"27","author":"Carver","year":"2009","journal-title":"World J Urol"},{"issue":"23","key":"10.1016\/j.annonc.2025.03.002_bib44","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1200\/JCO.22.02205","article-title":"Management of residual nonretroperitoneal disease in postchemotherapy nonseminomatous germ-cell tumors","volume":"41","author":"King","year":"2023","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753425001036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753425001036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T01:39:59Z","timestamp":1780277999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753425001036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0923753425001036"],"URL":"https:\/\/doi.org\/10.1016\/j.annonc.2025.03.002","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncologic outcomes of retroperitoneal lymph node dissection following first-line chemotherapy for metastatic non-seminomatous germ-cell tumors","name":"articletitle","label":"Article Title"},{"value":"Annals of Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annonc.2025.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society for Medical Oncology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}